Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDK13 anticorps (AA 1-170)

CDK13 Reactivité: Humain ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7373048
  • Antigène Voir toutes CDK13 Anticorps
    CDK13 (Cyclin-Dependent Kinase 13 (CDK13))
    Épitope
    • 6
    • 6
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-170
    Reactivité
    • 22
    • 22
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 30
    • 4
    Lapin
    Clonalité
    • 30
    • 4
    Polyclonal
    Conjugué
    • 13
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CDK13 est non-conjugé
    Application
    • 22
    • 22
    • 3
    • 2
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Cyclin-dependent kinase 13 protein (1-170AA)
    Isotype
    IgG
    Top Product
    Discover our top product CDK13 Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    CDK13 (Cyclin-Dependent Kinase 13 (CDK13))
    Autre désignation
    CDK13 (CDK13 Produits)
    Synonymes
    anticorps CDC2L5, anticorps cdc2l5, anticorps wu:fe16d10, anticorps wu:fi49c05, anticorps CDC2L, anticorps CHED, anticorps hCDK13, anticorps 2310015O17Rik, anticorps Cdc2l5, anticorps cyclin dependent kinase 13, anticorps cyclin-dependent kinase 13, anticorps CDK13, anticorps cdk13, anticorps Cdk13
    Sujet

    Background: Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at \'Lys-50\' and \'Lys-51\', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef.

    Aliases: CDC2 related protein kinase 5 antibody, CDC2-related protein kinase 5 antibody, CDC2L antibody, CDK13 antibody, CDK13_HUMAN antibody, cell division controller cholinesterase related antibody, cell division cycle 2 like 5 (cholinesterase related cell division controller) antibody, cell division cycle 2 like 5 antibody, Cell division cycle 2 like protein kinase 5 antibody, Cell division cycle 2-like protein kinase 5 antibody, Cell division protein kinase 13 antibody, CHED antibody, Cholinesterase related cell division controller antibody, Cholinesterase-related cell division controller antibody, cyclin dependent kinase 13 antibody, Cyclin-dependent kinase 13 antibody, hCDK13 antibody

    UniProt
    Q14004
Vous êtes ici:
Support technique